Potential Mechanisms of Action of Dietary Phytochemicals for Cancer Prevention by Targeting Cellular Signaling Transduction Pathways

Journal of Agricultural and Food Chemistry

Volumn 66, Issue 13, 2018, Pages 3260-3276

  Chen, Hongyu ^a,b   Liu, Rui Hai ^a  

^a Cornell University ^*  (United States)

^b INSTITUTE OF EDIBLE FUNGI   (China)

Author keywords

cancer; carcinogenesis; cellular signal transduction pathways; phytochemicals

Indexed keywords

BACTERIOPHAGES; CELL DEATH; DISEASES; PATHOLOGY; SIGNAL TRANSDUCTION; SIGNALING;

ANTICANCER ACTIVITIES; CANCER; CARCINOGENESIS; CELLULAR SIGNAL TRANSDUCTION; ECONOMICAL STRATEGY; PHYTOCHEMICALS; POST-TRANSCRIPTIONAL REGULATIONS; SIGNALING TRANSDUCTION;

CELL SIGNALING;

PHYTOCHEMICAL;

ANIMAL; DIET THERAPY; FRUIT; GENETICS; HUMAN; METABOLISM; NEOPLASM; SIGNAL TRANSDUCTION; VEGETABLE;

ANIMALS; FRUIT; HUMANS; NEOPLASMS; PHYTOCHEMICALS; SIGNAL TRANSDUCTION; VEGETABLES;

EID: 85044954346     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/acs.jafc.7b04975     Document Type: Review

References (244)

1. Stewart, B.; Wild, C. World Cancer Report, 2014, http://publications.iarc.fr/Non-Series-Publications/World-Cancer-Reports/World-Cancer-Report-2014.
2. Siegel, R. L.; Miller, K. D.; Jemal, A. Cancer Statistics, 2017. Ca-Cancer J. Clin. 2017, 67 (1), 7-30, 10.3322/caac.21387
3. Donaldson, M. S. Nutrition and cancer: a review of the evidence for an anti-cancer diet. Nutr. J. 2004, 3, 19, 10.1186/1475-2891-3-19
4. Bingham, S.; Riboli, E. Diet and cancer - the European Prospective Investigation into Cancer and Nutrition. Nat. Rev. Cancer 2004, 4 (3), 206-15, 10.1038/nrc1298
5. Surh, Y. J. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 2003, 3 (10), 768-80, 10.1038/nrc1189
6. Kotecha, R.; Takami, A.; Espinoza, J. L. Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence. Oncotarget 2016, 7 (32), 52517-52529, 10.18632/oncotarget.9593
7. Liu, R. H. Dietary bioactive compounds and their health implications. J. Food Sci. 2013, 78 (Suppl 1), A18-A25, 10.1111/1750-3841.12101
8. Le Marchand, L. Cancer preventive effects of flavonoids-a review. Biomed. Pharmacother. 2002, 56, 296-301, 10.1016/S0753-3322(02)00186-5
9. Liu, R. H. Health-promoting components of fruits and vegetables in the diet. Adv. Nutr. 2013, 4 (3), 384S-92S, 10.3945/an.112.003517
10. Turati, F.; Rossi, M.; Pelucchi, C.; Levi, F.; La Vecchia, C. Fruit and vegetables and cancer risk: a review of southern European studies. Br. J. Nutr. 2015, 113 (Suppl 2), S102-S110, 10.1017/S0007114515000148
11. Aune, D.; Chan, D. S.; Vieira, A. R.; Rosenblatt, D. A.; Vieira, R.; Greenwood, D. C.; Norat, T. Fruits, vegetables and breast cancer risk: a systematic review and meta-analysis of prospective studies. Breast Cancer Res. Treat. 2012, 134 (2), 479-93, 10.1007/s10549-012-2118-1
12. Vieira, A. R.; Vingeliene, S.; Chan, D. S.; Aune, D.; Abar, L.; Navarro Rosenblatt, D.; Greenwood, D. C.; Norat, T. Fruits, vegetables, and bladder cancer risk: a systematic review and meta-analysis. Cancer Med. 2015, 4 (1), 136-46, 10.1002/cam4.327
13. Lei, Q.; Zheng, H.; Bi, J.; Wang, X.; Jiang, T.; Gao, X.; Tian, F.; Xu, M.; Wu, C.; Zhang, L.; Li, N.; Li, J. Whole Grain Intake Reduces Pancreatic Cancer Risk: A Meta-Analysis of Observational Studies. Medicine (Philadelphia, PA, U. S.) 2016, 95 (9), e2747, 10.1097/MD.0000000000002747
14. Makarem, N.; Nicholson, J. M.; Bandera, E. V.; McKeown, N. M.; Parekh, N. Consumption of whole grains and cereal fiber in relation to cancer risk: a systematic review of longitudinal studies. Nutr. Rev. 2016, 74 (6), 353-73, 10.1093/nutrit/nuw003
15. Okarter, N.; Liu, R. H. Health benefits of whole grain phytochemicals. Crit. Rev. Food Sci. Nutr. 2010, 50 (3), 193-208, 10.1080/10408390802248734
16. Miller, P. E.; Snyder, D. C. Phytochemicals and cancer risk: a review of the epidemiological evidence. Nutr. Clin. Pract. 2012, 27 (5), 599-612, 10.1177/0884533612456043
17. HHS, USDA. 2015-2020 Dietary Guidelines for Americans, 8 th ed.; 2015; http://health.gov/dietaryguidelines/2015/guidelines/.
18. HemaIswarya, S.; Doble, M. Potential synergism of natural products in the treatment of cancer. Phytother. Res. 2006, 20 (4), 239-49, 10.1002/ptr.1841
19. WCRF. Link between lifestyle and cancer risk, http://www.wcrf.org/int/cancer-facts-figures/link-between-lifestyle-and-cancer-risk.
20. Melino, S.; Sabelli, R.; Paci, M. Allyl sulfur compounds and cellular detoxification system: effects and perspectives in cancer therapy. Amino Acids 2011, 41 (1), 103-12, 10.1007/s00726-010-0522-6
21. Slavin, J. L. Mechanisms for the Impact of Whole Grain Foods on Cancer Risk. J. Am. Coll. Nutr. 2000, 19 (sup3), 300S-307S, 10.1080/07315724.2000.10718964
22. Liu, R. H. Potential synergy of phytochemicals in cancer prevention: mechanism of action. J. Nutr. 2004, 134, 3479S-3485S, 10.1093/jn/134.12.3479S
23. Chen, C. H.; Huang, T. S.; Wong, C. H.; Hong, C. L.; Tsai, Y. H.; Liang, C. C.; Lu, F. J.; Chang, W. H. Synergistic anti-cancer effect of baicalein and silymarin on human hepatoma HepG2 Cells. Food Chem. Toxicol. 2009, 47 (3), 638-44, 10.1016/j.fct.2008.12.024
24. Yang, J.; Liu, R. H. Synergistic effect of apple extracts and quercetin 3-beta-d-glucoside combination on antiproliferative activity in MCF-7 human breast cancer cells in vitro. J. Agric. Food Chem. 2009, 57 (18), 8581-6, 10.1021/jf8039796
25. Singh, B. N.; Singh, H. B.; Singh, A.; Naqvi, A. H.; Singh, B. R. Dietary phytochemicals alter epigenetic events and signaling pathways for inhibition of metastasis cascade: phytoblockers of metastasis cascade. Cancer Metastasis Rev. 2014, 33 (1), 41-85, 10.1007/s10555-013-9457-1
26. Sukumari-Ramesh, S.; Bentley, J. N.; Laird, M. D.; Singh, N.; Vender, J. R.; Dhandapani, K. M. Dietary phytochemicals induce p53- and caspase-independent cell death in human neuroblastoma cells. Int. J. Dev. Neurosci. 2011, 29 (7), 701-10, 10.1016/j.ijdevneu.2011.06.002
27. Huang, C. H.; Jan, R. L.; Kuo, C. H.; Chu, Y. T.; Wang, W. L.; Lee, M. S.; Chen, H. N.; Hung, C. H. Natural flavone kaempferol suppresses chemokines expression in human monocyte THP-1 cells through MAPK pathways. J. Food Sci. 2010, 75 (8), H254-9, 10.1111/j.1750-3841.2010.01812.x
28. Bahramsoltani, R.; Farzaei, M. H.; Farahani, M. S.; Rahimi, R. Phytochemical constituents as future antidepressants: a comprehensive review. Rev. Neurosci. 2015, 26 (6), 699-719, 10.1515/revneuro-2015-0009
29. Michael, J. P. Quinoline, quinazoline and acridone alkaloids. Nat. Prod. Rep. 2008, 25 (1), 166-87, 10.1039/B612168N
30. Cassidy, A.; Hanley, B.; Lamuela-Raventos, R. M. Isoflavones, lignans and stilbenes-origins, metabolism and potential importance to human health. J. Sci. Food Agric. 2000, 80 (7), 1044-1062, 10.1002/(SICI)1097-0010(20000515)80:7<1044::AID-JSFA586>3.0.CO;2-N
31. Michael, J. P. Indolizidine and quinolizidine alkaloids. Nat. Prod. Rep. 2008, 25 (1), 139-65, 10.1039/B612166G
32. Martins, S.; Mussatto, S. I.; Martinez-Avila, G.; Montanez-Saenz, J.; Aguilar, C. N.; Teixeira, J. A. Bioactive phenolic compounds: production and extraction by solid-state fermentation. A review. Biotechnol. Adv. 2011, 29 (3), 365-73, 10.1016/j.biotechadv.2011.01.008
33. Liu, Y.; Yin, T.; Feng, Y.; Cona, M. M.; Huang, G.; Liu, J.; Song, S.; Jiang, Y.; Xia, Q.; Swinnen, J. V.; Bormans, G.; Himmelreich, U.; Oyen, R.; Ni, Y. Mammalian models of chemically induced primary malignancies exploitable for imaging-based preclinical theragnostic research. Quant. Imaging Med. Surg. 2015, 5 (5), 708-729, 10.3978/j.issn.2223-4292.2015.06.01
34. Schroeder, A.; Heller, D. A.; Winslow, M. M.; Dahlman, J. E.; Pratt, G. W.; Langer, R.; Jacks, T.; Anderson, D. G. Treating metastatic cancer with nanotechnology. Nat. Rev. Cancer 2012, 12 (1), 39-50, 10.1038/nrc3180
35. Sung, B.; Prasad, S.; Yadav, V. R.; Aggarwal, B. B. Cancer cell signaling pathways targeted by spice-derived nutraceuticals. Nutr. Cancer 2012, 64 (2), 173-97, 10.1080/01635581.2012.630551
36. Koury, J.; Zhong, L.; Hao, J. Targeting Signaling Pathways in Cancer Stem Cells for Cancer Treatment. Stem Cells Int. 2017, 2017, 2925869, 10.1155/2017/2925869
37. Reya, T.; Clevers, H. Wnt signalling in stem cells and cancer. Nature 2005, 434 (7035), 843-50, 10.1038/nature03319
38. Arends, M. J. Pathways of colorectal carcinogenesis. Appl. Immunohistochem. Mol. Morphol. 2013, 21 (2), 97-102, 10.1097/PAI.0b013e31827ea79e
39. Quail, D. F.; Joyce, J. A. Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 2013, 19 (11), 1423-37, 10.1038/nm.3394
40. Soto, M. L.; Moure, A.; Domínguez, H.; Parajó, J. C. Recovery, concentration and purification of phenolic compounds by adsorption: A review. J. Food Eng. 2011, 105 (1), 1-27, 10.1016/j.jfoodeng.2011.02.010
41. Karakaya, S. Bioavailability of phenolic compounds. Crit. Rev. Food Sci. Nutr. 2004, 44 (6), 453-64, 10.1080/10408690490886683
42. Boudet, A. M. Evolution and current status of research in phenolic compounds. Phytochemistry 2007, 68 (22-24), 2722-35, 10.1016/j.phytochem.2007.06.012
43. Crozier, A.; Del Rio, D.; Clifford, M. N. Bioavailability of dietary flavonoids and phenolic compounds. Mol. Aspects Med. 2010, 31 (6), 446-67, 10.1016/j.mam.2010.09.007
44. Haminiuk, C. W. I.; Maciel, G. M.; Plata-Oviedo, M. S. V.; Peralta, R. M. Phenolic compounds in fruits-an overview. Int. J. Food Sci. Technol. 2012, 47 (10), 2023-2044, 10.1111/j.1365-2621.2012.03067.x
45. Chu, C. C.; Wu, W. S.; Shieh, J. P.; Chu, H. L.; Lee, C. P.; Duh, P. D. The Anti-Inflammatory and Vasodilating Effects of Three Selected Dietary Organic Sulfur Compounds from Allium Species. J. Funct. Biomater. 2017, 8 (4), 5, 10.3390/jfb8010005
46. Robertson, J.; Stevens, K. Pyrrolizidine alkaloids. Nat. Prod. Rep. 2014, 31 (12), 1721-88, 10.1039/C4NP00055B
47. Hanahan, D.; Weinberg, R. A. The Hallmarks of Cancer. Cell 2000, 100 (1), 57-70, 10.1016/S0092-8674(00)81683-9
48. Tomasetti, C.; Li, L.; Vogelstein, B. Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention. Science 2017, 355 (6331), 1330-1334, 10.1126/science.aaf9011
49. Barrett, J. C. Mechanisms of multistep carcinogenesis and carcinogen risk assessment. Environ. Health Perspect 1993, 100, 9-20, 10.1289/ehp.931009
50. Land, H.; Parada, L. F.; Weinberg, R. A. Cellular oncogenes and multistep carcinogenesis. Science 1983, 222, 771, 10.1126/science.6356358
51. Berenblum, I.; Shubik, P. A New, Quantitative, Approach to the Study of the Stages of Chemical Carcinogenesis in the Mouse's Skin. Br. J. Cancer 1947, 1, 383-391, 10.1038/bjc.1947.36
52. Cohen, S. M.; Arnold, L. L. Chemical carcinogenesis. Toxicol. Sci. 2011, 120 (Suppl 1), S76-92, 10.1093/toxsci/kfq365
53. Barret, J. C. Molecular mechanisms of carcinogenesis in humans and rodents. Mol. Carcinog. 1993, 7 (1), 1-13, 10.1002/mc.2940070102
54. Stacker, S. A.; Achen, M. G.; Jussila, L.; Baldwin, M. E.; Alitalo, K. Lymphangiogenesis and cancer metastasis. Nat. Rev. Cancer 2002, 2 (8), 573-83, 10.1038/nrc863
55. van Zijl, F.; Krupitza, G.; Mikulits, W. Initial steps of metastasis: cell invasion and endothelial transmigration. Mutat. Res., Rev. Mutat. Res. 2011, 728 (1-2), 23-34, 10.1016/j.mrrev.2011.05.002
56. Dhillon, A. S.; Hagan, S.; Rath, O.; Kolch, W. MAP kinase signalling pathways in cancer. Oncogene 2007, 26 (22), 3279-90, 10.1038/sj.onc.1210421
57. Lee, K. H.; Hyun, M. S.; Kim, J. R. Growth factor-dependent activation of the MAPK pathway in human pancreatic cancer: MEK/ERK and p38 MAP kinase interaction in uPA synthesis. Clin. Exp. Metastasis 2003, 20 (6), 499-505, 10.1023/A:1025824816021
58. Haldar, S.; Basu, A.; Croce, C. M. Bcl2 is the guardian of microtubule integrity. Cancer Res. 1997, 57 (2), 229-233
59. Overall, C. M.; Lopez-Otin, C. Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat. Rev. Cancer 2002, 2 (9), 657-72, 10.1038/nrc884
60. Talalay, P. Mechanisms of induction of enzymes that protect against chemical carcinogenesis. Adv. Enzyme Regul. 1989, 28, 237-250, 10.1016/0065-2571(89)90074-5
61. Hassan, I.; Jabir, N. R.; Ahmad, S.; Shah, A.; Tabrez, S. Certain Phase I and II Enzymes as Toxicity Biomarker: An Overview. Water Air Soil Pollut. 2015, 226 (5), 153, 10.1007/s11270-015-2429-z
62. Owen, R. W.; Giacosa, A.; Hull, W. E.; Haubner, R.; Spiegelhalder, B.; Bartsch, H. The antioxidant/anticancer potential of phenolic compounds isolated from olive oil. Eur. J. Cancer 2000, 36 (10), 1235-1247, 10.1016/S0959-8049(00)00103-9
63. Forester, S. C.; Lambert, J. D. The role of antioxidant versus pro-oxidant effects of green tea polyphenols in cancer prevention. Mol. Nutr. Food Res. 2011, 55 (6), 844-54, 10.1002/mnfr.201000641
64. Roleira, F. M.; Tavares-da-Silva, E. J.; Varela, C. L.; Costa, S. C.; Silva, T.; Garrido, J.; Borges, F. Plant derived and dietary phenolic antioxidants: anticancer properties. Food Chem. 2015, 183, 235-58, 10.1016/j.foodchem.2015.03.039
65. Wang, H.; Khor, T. O.; Yang, Q.; Huang, Y.; Wu, T. Y.; Saw, C. L.; Lin, W.; Androulakis, I. P.; Kong, A. N. Pharmacokinetics and pharmacodynamics of phase II drug metabolizing/antioxidant enzymes gene response by anticancer agent sulforaphane in rat lymphocytes. Mol. Pharmaceutics 2012, 9 (10), 2819-27, 10.1021/mp300130k
66. Bowen-Forbes, C. S.; Zhang, Y.; Nair, M. G. Anthocyanin content, antioxidant, anti-inflammatory and anticancer properties of blackberry and raspberry fruits. J. Food Compos. Anal. 2010, 23 (6), 554-560, 10.1016/j.jfca.2009.08.012
67. Davenport, D. M.; Wargovich, M. J. Modulation of cytochrome P450 enzymes by organosulfur compounds from garlic. Food Chem. Toxicol. 2005, 43 (12), 1753-62, 10.1016/j.fct.2005.05.018
68. Mittal, B.; Tulsyan, S.; Kumar, S.; Mittal, R. D.; Agarwal, G. Cytochrome P450 in Cancer Susceptibility and Treatment. Adv. Clin. Chem. 2015, 71, 77-139, 10.1016/bs.acc.2015.06.003
69. Gelboin, H. V.; Krausz, K. W.; Goldfarb, I.; Buters, J. T. M.; Yang, S. K.; Gonzalez, F. J.; Korzekwa, K. R.; Shou, M. Inhibitory and non-inhibitory monoclonal antibodies to human cytochrome P450 3A3/4. Biochem. Pharmacol. 1995, 50 (11), 1841-1850, 10.1016/0006-2952(95)02077-2
70. Omura, T. Forty years of cytochrome P450. Biochem. Biophys. Res. Commun. 1999, 266 (3), 690-8, 10.1006/bbrc.1999.1887
71. Moon, Y. J.; Wang, X.; Morris, M. E. Dietary flavonoids: effects on xenobiotic and carcinogen metabolism. Toxicol. In Vitro 2006, 20 (2), 187-210, 10.1016/j.tiv.2005.06.048
72. Obermeier, M. T.; White, R. E.; Yang, C. S. Effects of bioflavonoids on hepatic P450 activities. Xenobiotica 1995, 25 (6), 575-84, 10.3109/00498259509061876
73. Fuhr, U.; Klittich, K.; Staib, A. H. Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man. Br. J. Clin. Pharmacol. 1993, 35 (4), 431-436, 10.1111/j.1365-2125.1993.tb04162.x
74. Uno, T.; Ogura, C.; Izumi, C.; Nakamura, M.; Yanase, T.; Yamazaki, H.; Ashida, H.; Kanamaru, K.; Yamagata, H.; Imaishi, H. Point mutation of cytochrome P450 2A6 (a polymorphic variant CYP2A6.25) confers new substrate specificity towards flavonoids. Biopharm. Drug Dispos. 2015, 36 (8), 552-63, 10.1002/bdd.1966
75. Itoh, K.; Mimura, J.; Yamamoto, M. Discovery of the negative regulator of Nrf2, Keap1: a historical overview. Antioxid. Redox Signaling 2010, 13 (11), 1665-78, 10.1089/ars.2010.3222
76. Itoh, K.; Chiba, T.; Takahashi, S.; Ishii, T.; Igarashi, K.; Katoh, Y.; Oyake, T.; Hayashi, N.; Satoh, K.; Hatayama, I.; Yamamoto, M.; Nabeshima, Y.-i. An Nrf2/Small Maf Heterodimer Mediates the Induction of Phase II Detoxifying Enzyme Genes through Antioxidant Response Elements. Biochem. Biophys. Res. Commun. 1997, 236 (2), 313-322, 10.1006/bbrc.1997.6943
77. Fukunaga, B. N.; Probst, M. R.; Reisz-Porszasz, S.; Hankinson, O. Identification of Functional Domains of the Aryl Hydrocarbon Receptor. J. Biol. Chem. 1995, 270 (49), 29270-29278, 10.1074/jbc.270.49.29270
78. Menegon, S.; Columbano, A.; Giordano, S. The Dual Roles of NRF2 in Cancer. Trends Mol. Med. 2016, 22 (7), 578-93, 10.1016/j.molmed.2016.05.002
79. Tkachev, V. O.; Menshchikova, E. B.; Zenkov, N. K. Mechanism of the Nrf2/Keap1/ARE signaling system. Biochemistry (Moscow) 2011, 76 (4), 407-422, 10.1134/S0006297911040031
80. Itoh, K.; Wakabayashi, N.; Katoh, Y.; Ishii, T.; Igarashi, K.; Engel, J. D.; Yamamoto, M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 1999, 13 (1), 76-86, 10.1101/gad.13.1.76
81. Liu, J.; Ma, L.; Chen, X.; Wang, J.; Yu, T.; Gong, Y.; Ma, A.; Zheng, L.; Liang, H. ERK inhibition sensitizes cancer cells to oleanolic acid-induced apoptosis through ERK/Nrf2/ROS pathway. Tumor Biol. 2016, 37 (6), 8181-8187, 10.1007/s13277-015-4668-4
82. Zipper, L. M.; Mulcahy, R. T. Erk activation is required for Nrf2 nuclear localization during pyrrolidine dithiocarbamate induction of glutamate cysteine ligase modulatory gene expression in HepG2 cells. Toxicol. Sci. 2003, 73 (1), 124-34, 10.1093/toxsci/kfg083
83. Hu, R.; Xu, C.; Shen, G.; Jain, M. R.; Khor, T. O.; Gopalkrishnan, A.; Lin, W.; Reddy, B.; Chan, J. Y.; Kong, A. N. Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice. Cancer Lett. 2006, 243 (2), 170-92, 10.1016/j.canlet.2005.11.050
84. Wu, C. C.; Hsu, M. C.; Hsieh, C. W.; Lin, J. B.; Lai, P. H.; Wung, B. S. Upregulation of heme oxygenase-1 by Epigallocatechin-3-gallate via the phosphatidylinositol 3-kinase/Akt and ERK pathways. Life Sci. 2006, 78 (25), 2889-97, 10.1016/j.lfs.2005.11.013
85. Martin, D.; Rojo, A. I.; Salinas, M.; Diaz, R.; Gallardo, G.; Alam, J.; De Galarreta, C. M.; Cuadrado, A. Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol. J. Biol. Chem. 2004, 279 (10), 8919-29, 10.1074/jbc.M309660200
86. Balogun, E.; Hoque, M.; Gong, P.; Killeen, E.; Green, C. J.; Foresti, R.; Alam, J.; Motterlini, R. Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem. J. 2003, 371 (3), 887-895, 10.1042/bj20021619
87. Pandurangan, A. K.; Saadatdoust, Z.; Esa, N. M.; Hamzah, H.; Ismail, A. Dietary cocoa protects against colitis-associated cancer by activating the Nrf2/Keap1 pathway. Biofactors 2015, 41 (1), 1-14, 10.1002/biof.1195
88. Chen, B.; Zhang, Y.; Wang, Y.; Rao, J.; Jiang, X.; Xu, Z. Curcumin inhibits proliferation of breast cancer cells through Nrf2-mediated down-regulation of Fen1 expression. J. Steroid Biochem. Mol. Biol. 2014, 143, 11-8, 10.1016/j.jsbmb.2014.01.009
89. Zhang, C.; Su, Z. Y.; Khor, T. O.; Shu, L.; Kong, A. N. Sulforaphane enhances Nrf2 expression in prostate cancer TRAMP C1 cells through epigenetic regulation. Biochem. Pharmacol. 2013, 85 (9), 1398-404, 10.1016/j.bcp.2013.02.010
90. Su, Z. Y.; Khor, T. O.; Shu, L.; Lee, J. H.; Saw, C. L.; Wu, T. Y.; Huang, Y.; Suh, N.; Yang, C. S.; Conney, A. H.; Wu, Q.; Kong, A. N. Epigenetic reactivation of Nrf2 in murine prostate cancer TRAMP C1 cells by natural phytochemicals Z-ligustilide and Radix angelica sinensis via promoter CpG demethylation. Chem. Res. Toxicol. 2013, 26 (3), 477-85, 10.1021/tx300524p
91. Furfaro, A. L.; Traverso, N.; Domenicotti, C.; Piras, S.; Moretta, L.; Marinari, U. M.; Pronzato, M. A.; Nitti, M. The Nrf2/HO-1 Axis in Cancer Cell Growth and Chemoresistance. Oxid. Med. Cell. Longevity 2016, 2016, 1958174, 10.1155/2016/1958174
92. Michl, C.; Vivarelli, F.; Weigl, J.; De Nicola, G. R.; Canistro, D.; Paolini, M.; Iori, R.; Rascle, A. The Chemopreventive Phytochemical Moringin Isolated from Moringa oleifera Seeds Inhibits JAK/STAT Signaling. PLoS One 2016, 11 (6), e0157430, 10.1371/journal.pone.0157430
93. Burotto, M.; Chiou, V. L.; Lee, J. M.; Kohn, E. C. The MAPK pathway across different malignancies: a new perspective. Cancer 2014, 120 (22), 3446-56, 10.1002/cncr.28864
94. Bonni, A.; Brunet, A.; West, A. E.; Datta, S. R.; Takasu, M. A.; Greenberg, M. E. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 1999, 286 (5443), 1358-1362, 10.1126/science.286.5443.1358
95. Gallo, K. A.; Johnson, G. L. Mixed-lineage kinase control of JNK and p38 MAPK pathways. Nat. Rev. Mol. Cell Biol. 2002, 3 (9), 663-72, 10.1038/nrm906
96. Chen, Y.-R.; Wang, X.; Templeton, D.; Davis, R. J.; Tan, T.-H. The Role of c-Jun N-terminal Kinase (JNK) in Apoptosis Induced by Ultraviolet C and γ Radiation. J. Biol. Chem. 1996, 271 (50), 31929-31936, 10.1074/jbc.271.50.31929
97. Wu, C. C.; Cheng, C. H.; Lee, Y. H.; Chang, I. L.; Chen, H. Y.; Hsieh, C. P.; Chueh, P. J. Ursolic Acid Triggers Apoptosis in Human Osteosarcoma Cells via Caspase Activation and the ERK1/2 MAPK Pathway. J. Agric. Food Chem. 2016, 64 (21), 4220-6, 10.1021/acs.jafc.6b00542
98. Kang, K. A.; Piao, M. J.; Madduma Hewage, S. R.; Ryu, Y. S.; Oh, M. C.; Kwon, T. K.; Chae, S.; Hyun, J. W. Fisetin induces apoptosis and endoplasmic reticulum stress in human non-small cell lung cancer through inhibition of the MAPK signaling pathway. Tumor Biol. 2016, 37 (7), 9615-24, 10.1007/s13277-016-4864-x
99. Ecker, B. M.; Stein, J.; Ulrich, S. 695 Sulforaphane Sensitizes Colorectal Cancer Cells to Oxaliplatin Induced Cell Growth Inhibition: Key Role of p38 MAPK. Gastroenterology 2009, 136 (5), A-109, 10.1016/S0016-5085(09)60490-X
100. Adachi, S.; Shimizu, M.; Shirakami, Y.; Yamauchi, J.; Natsume, H.; Matsushima-Nishiwaki, R.; To, S.; Weinstein, I. B.; Moriwaki, H.; Kozawa, O. (-)-Epigallocatechin gallate downregulates EGF receptor via phosphorylation at Ser1046/1047 by p38 MAPK in colon cancer cells. Carcinogenesis 2009, 30 (9), 1544-52, 10.1093/carcin/bgp166
101. Li, Y.; Lu, X.; Qi, H.; Li, X.; Xiao, X.; Gao, J. Ursolic Acid Induces Apoptosis Through Mitochondrial Intrinsic Pathway and Suppression of ERK1/2 MAPK in HeLa Cells. J. Pharmacol. Sci. 2014, 125 (2), 202-210, 10.1254/jphs.14017FP
102. Cao, L.; Chen, X.; Xiao, X.; Ma, Q.; Li, W. Resveratrol inhibits hyperglycemia-driven ROS-induced invasion and migration of pancreatic cancer cells via suppression of the ERK and p38 MAPK signaling pathways. Int. J. Oncol. 2016, 49 (2), 735-43, 10.3892/ijo.2016.3559
103. Ryu, M. J.; Chung, H. S. [10]-Gingerol induces mitochondrial apoptosis through activation of MAPK pathway in HCT116 human colon cancer cells. In Vitro Cell. Dev. Biol.: Anim. 2015, 51 (1), 92-101, 10.1007/s11626-014-9806-6
104. Jin, C. Y.; Park, C.; Kim, G. Y.; Lee, S. J.; Kim, W. J.; Choi, Y. H. Genistein enhances TRAIL-induced apoptosis through inhibition of p38 MAPK signaling in human hepatocellular carcinoma Hep3B cells. Chem.-Biol. Interact. 2009, 180 (2), 143-50, 10.1016/j.cbi.2009.03.020
105. Porta, C.; Paglino, C.; Mosca, A. Targeting PI3K/Akt/mTOR Signaling in Cancer. Front. Oncol. 2014, 4, 64, 10.3389/fonc.2014.00064
106. Karar, J.; Maity, A. PI3K/AKT/mTOR Pathway in Angiogenesis. Front. Mol. Neurosci. 2011, 4, 51, 10.3389/fnmol.2011.00051
107. Campbell, R. A.; Bhat-Nakshatri, P.; Patel, N. M.; Constantinidou, D.; Ali, S.; Nakshatri, H. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. J. Biol. Chem. 2001, 276 (13), 9817-24, 10.1074/jbc.M010840200
108. Mundi, P. S.; Sachdev, J.; McCourt, C.; Kalinsky, K. AKT in cancer: new molecular insights and advances in drug development. Br. J. Clin. Pharmacol. 2016, 82 (4), 943-56, 10.1111/bcp.13021
109. Elstrom, R. L.; Bauer, D. E.; Buzzai, M.; Karnauskas, R.; Harris, M. H.; Plas, D. R.; Zhuang, H.; Cinalli, R. M.; Alavi, A.; Rudin, C. M.; Thompson, C. B. Akt stimulates aerobic glycolysis in cancer cells. Cancer Res. 2004, 64 (11), 3892-9, 10.1158/0008-5472.CAN-03-2904
110. Schmidt, M.; Voelker, H. U.; Kapp, M.; Krockenberger, M.; Dietl, J.; Kammerer, U. Glycolytic phenotype in breast cancer: activation of Akt, up-regulation of GLUT1, TKTL1 and down-regulation of M2PK. J. Cancer Res. Clin. Oncol. 2010, 136 (2), 219-25, 10.1007/s00432-009-0652-y
111. Yang, L.; Dan, H. C.; Sun, M.; Liu, Q.; Sun, X. M.; Feldman, R. I.; Hamilton, A. D.; Polokoff, M.; Nicosia, S. V.; Herlyn, M.; Sebti, S. M.; Cheng, J. Q. Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt. Cancer Res. 2004, 64 (13), 4394-9, 10.1158/0008-5472.CAN-04-0343
112. Fresno Vara, J. A.; Casado, E.; de Castro, J.; Cejas, P.; Belda-Iniesta, C.; Gonzalez-Baron, M. PI3K/Akt signalling pathway and cancer. Cancer Treat. Rev. 2004, 30 (2), 193-204, 10.1016/j.ctrv.2003.07.007
113. Ho, H. H.; Chang, C. S.; Ho, W. C.; Liao, S. Y.; Wu, C. H.; Wang, C. J. Anti-metastasis effects of gallic acid on gastric cancer cells involves inhibition of NF-kappaB activity and downregulation of PI3K/AKT/small GTPase signals. Food Chem. Toxicol. 2010, 48 (8-9), 2508-16, 10.1016/j.fct.2010.06.024
114. Park, C. M.; Jin, K. S.; Lee, Y. W.; Song, Y. S. Luteolin and chicoric acid synergistically inhibited inflammatory responses via inactivation of PI3K-Akt pathway and impairment of NF-kappaB translocation in LPS stimulated RAW 264.7 cells. Eur. J. Pharmacol. 2011, 660 (2-3), 454-9, 10.1016/j.ejphar.2011.04.007
115. Roy, P.; Kalra, N.; Prasad, S.; George, J.; Shukla, Y. Chemopreventive potential of resveratrol in mouse skin tumors through regulation of mitochondrial and PI3K/AKT signaling pathways. Pharm. Res. 2009, 26 (1), 211-7, 10.1007/s11095-008-9723-z
116. Zanotto-Filho, A.; Braganhol, E.; Edelweiss, M. I.; Behr, G. A.; Zanin, R.; Schroder, R.; Simoes-Pires, A.; Battastini, A. M.; Moreira, J. C. The curry spice curcumin selectively inhibits cancer cells growth in vitro and in preclinical model of glioblastoma. J. Nutr. Biochem. 2012, 23 (6), 591-601, 10.1016/j.jnutbio.2011.02.015
117. Sun, Z. J.; Chen, G.; Hu, X.; Zhang, W.; Liu, Y.; Zhu, L. X.; Zhou, Q.; Zhao, Y. F. Activation of PI3K/Akt/IKK-alpha/NF-kappaB signaling pathway is required for the apoptosis-evasion in human salivary adenoid cystic carcinoma: its inhibition by quercetin. Apoptosis 2010, 15 (7), 850-63, 10.1007/s10495-010-0497-5
118. Prasad, R.; Vaid, M.; Katiyar, S. K. Grape proanthocyanidin inhibit pancreatic cancer cell growth in vitro and in vivo through induction of apoptosis and by targeting the PI3K/Akt pathway. PLoS One 2012, 7 (8), e43064, 10.1371/journal.pone.0043064
119. Shin, D. Y.; Kim, G. Y.; Lee, J. H.; Choi, B. T.; Yoo, Y. H.; Choi, Y. H. Apoptosis induction of human prostate carcinoma DU145 cells by diallyl disulfide via modulation of JNK and PI3K/AKT signaling pathways. Int. J. Mol. Sci. 2012, 13 (11), 14158-71, 10.3390/ijms131114158
120. Lin, C. H.; Chang, C. Y.; Lee, K. R.; Lin, H. J.; Chen, T. H.; Wan, L. Flavones inhibit breast cancer proliferation through the Akt/FOXO3a signaling pathway. BMC Cancer 2015, 15, 958, 10.1186/s12885-015-1965-7
121. Pawlik, A.; Wiczk, A.; Kaczynska, A.; Antosiewicz, J.; Herman-Antosiewicz, A. Sulforaphane inhibits growth of phenotypically different breast cancer cells. Eur. J. Nutr. 2013, 52 (8), 1949-58, 10.1007/s00394-013-0499-5
122. Shukla, S.; Bhaskaran, N.; Babcook, M. A.; Fu, P.; Maclennan, G. T.; Gupta, S. Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway. Carcinogenesis 2014, 35 (2), 452-60, 10.1093/carcin/bgt316
123. Wang, D.; Wise, M. L.; Li, F.; Dey, M. Phytochemicals attenuating aberrant activation of beta-catenin in cancer cells. PLoS One 2012, 7 (12), e50508, 10.1371/journal.pone.0050508
124. Smalley, M. J.; Dale, T. C. Wnt Signalling in Mammalian Development and Cancer.pdf. Cancer Metastasis Rev. 1999, 18 (2), 215-230, 10.1023/A:1006369223282
125. Driehuis, E.; Clevers, H. WNT signalling events near the cell membrane and their pharmacological targeting for the treatment of cancer. Br. J. Pharmacol. 2017, 174, 4547, 10.1111/bph.13758
126. Taipale, J.; Beachy, P. A. The Hedgehog and Wnt signalling pathways in cancer. Nature 2001, 411 (6835), 349-54, 10.1038/35077219
127. Tsai, J. H.; Hsu, L. S.; Lin, C. L.; Hong, H. M.; Pan, M. H.; Way, T. D.; Chen, W. J. 3,5,4′-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/beta-catenin signaling cascades and reversal of epithelial-mesenchymal transition. Toxicol. Appl. Pharmacol. 2013, 272 (3), 746-56, 10.1016/j.taap.2013.07.019
128. Oh, S.; Gwak, J.; Park, S.; Yang, C. S. Green tea polyphenol EGCG suppresses Wnt/beta-catenin signaling by promoting GSK-3beta- and PP2A-independent beta-catenin phosphorylation/degradation. Biofactors 2014, 40 (6), 586-95, 10.1002/biof.1185
129. Tejeda-Munoz, N.; Robles-Flores, M. Glycogen synthase kinase 3 in Wnt signaling pathway and cancer. IUBMB Life 2015, 67 (12), 914-22, 10.1002/iub.1454
130. Yu, H.; Lee, H.; Herrmann, A.; Buettner, R.; Jove, R. Revisiting STAT3 signalling in cancer: new and unexpected biological functions. Nat. Rev. Cancer 2014, 14 (11), 736-46, 10.1038/nrc3818
131. Abell, K.; Watson, C. J. The Jak/Stat pathway: a novel way to regulate PI3K activity. Cell Cycle 2005, 4 (7), 897-900, 10.4161/cc.4.7.1837
132. Schindler, C.; Darnell, J. E., Jr. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 1995, 64, 621-51, 10.1146/annurev.bi.64.070195.003201
133. Rawlings, J. S.; Rosler, K. M.; Harrison, D. A. The JAK/STAT signaling pathway. J. Cell Sci. 2004, 117 (Pt 8), 1281-3, 10.1242/jcs.00963
134. Yu, H.; Jove, R. The STATs of cancer - new molecular targets come of age. Nat. Rev. Cancer 2004, 4 (2), 97-105, 10.1038/nrc1275
135. Bromberg, J.; Wang, T. C. Inflammation and cancer: IL-6 and STAT3 complete the link. Cancer Cell 2009, 15 (2), 79-80, 10.1016/j.ccr.2009.01.009
136. Kim, D. H.; Park, K. W.; Chae, I. G.; Kundu, J.; Kim, E. H.; Kundu, J. K.; Chun, K. S. Carnosic acid inhibits STAT3 signaling and induces apoptosis through generation of ROS in human colon cancer HCT116 cells. Mol. Carcinog. 2016, 55 (6), 1096-110, 10.1002/mc.22353
137. Muller, P. A.; Vousden, K. H. p53 mutations in cancer. Nat. Cell Biol. 2013, 15 (1), 2-8, 10.1038/ncb2641
138. Rueda-Rincon, N.; Bloch, K.; Derua, R.; Vyas, R.; Harms, A.; Hankemeier, T.; Khan, N. A.; Dehairs, J.; Bagadi, M.; Binda, M. M.; Waelkens, E.; Marine, J. C.; Swinnen, J. V. p53 attenuates AKT signaling by modulating membrane phospholipid composition. Oncotarget 2015, 6 (25), 21240-21254, 10.18632/oncotarget.4067
139. Wu, G. S. The functional Interactions Between the MAPK and p53 Signaling Pathways. Cancer Biol. Ther. 2004, 3 (2), 156-161, 10.4161/cbt.3.2.614
140. Gottlieb, T. M.; Leal, J. F. M.; Seger, R.; Taya, Y.; Oren, M. Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosis. Oncogene 2002, 21 (8), 1299-1303, 10.1038/sj.onc.1205181
141. Toshiyuki, M.; Reed, J. C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995, 80 (2), 293-299, 10.1016/0092-8674(95)90412-3
142. van Ginkel, P. R.; Yan, M. B.; Bhattacharya, S.; Polans, A. S.; Kenealey, J. D. Natural products induce a G protein-mediated calcium pathway activating p53 in cancer cells. Toxicol. Appl. Pharmacol. 2015, 288 (3), 453-62, 10.1016/j.taap.2015.08.016
143. Xavier, C. P.; Lima, C. F.; Rohde, M.; Pereira-Wilson, C. Quercetin enhances 5-fluorouracil-induced apoptosis in MSI colorectal cancer cells through p53 modulation. Cancer Chemother. Pharmacol. 2011, 68 (6), 1449-57, 10.1007/s00280-011-1641-9
144. Wang, X.; Bai, H.; Zhang, X.; Liu, J.; Cao, P.; Liao, N.; Zhang, W.; Wang, Z.; Hai, C. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis. Carcinogenesis 2013, 34 (6), 1323-30, 10.1093/carcin/bgt058
145. Cho, J. H.; Lee, J. G.; Yang, Y. I.; Kim, J. H.; Ahn, J. H.; Baek, N. I.; Lee, K. T.; Choi, J. H. Eupatilin, a dietary flavonoid, induces G2/M cell cycle arrest in human endometrial cancer cells. Food Chem. Toxicol. 2011, 49 (8), 1737-44, 10.1016/j.fct.2011.04.019
146. Cordero-Herrera, I.; Martin, M. A.; Bravo, L.; Goya, L.; Ramos, S. Epicatechin gallate induces cell death via p53 activation and stimulation of p38 and JNK in human colon cancer SW480 cells. Nutr. Cancer 2013, 65 (5), 718-28, 10.1080/01635581.2013.795981
147. Lemasters, J. J.; Nieminen, A. L.; Qian, T.; Trost, L. C.; Elmore, S. P.; Nishimura, Y.; Crowe, R. A.; Cascio, W. E.; Bradham, C. A.; Brenner, D. A.; Herman, B. The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim. Biophys. Acta, Bioenerg. 1998, 1366 (1-2), 177-96, 10.1016/S0005-2728(98)00112-1
148. Mathew, R.; Karantza-Wadsworth, V.; White, E. Role of autophagy in cancer. Nat. Rev. Cancer 2007, 7 (12), 961-7, 10.1038/nrc2254
149. White, E. The role for autophagy in cancer. J. Clin. Invest. 2015, 125 (1), 42-6, 10.1172/JCI73941
150. Hippert, M. M.; O'Toole, P. S.; Thorburn, A. Autophagy in cancer: good, bad, or both?. Cancer Res. 2006, 66 (19), 9349-51, 10.1158/0008-5472.CAN-06-1597
151. Thorburn, A.; Thamm, D. H.; Gustafson, D. L. Autophagy and cancer therapy. Mol. Pharmacol. 2014, 85 (6), 830-8, 10.1124/mol.114.091850
152. Rosenfeldt, M. T.; O'Prey, J.; Morton, J. P.; Nixon, C.; MacKay, G.; Mrowinska, A.; Au, A.; Rai, T. S.; Zheng, L.; Ridgway, R.; Adams, P. D.; Anderson, K. I.; Gottlieb, E.; Sansom, O. J.; Ryan, K. M. p53 status determines the role of autophagy in pancreatic tumour development. Nature 2013, 504 (7479), 296-300, 10.1038/nature12865
153. Lewinska, A.; Adamczyk-Grochala, J.; Kwasniewicz, E.; Deregowska, A.; Wnuk, M. Ursolic acid-mediated changes in glycolytic pathway promote cytotoxic autophagy and apoptosis in phenotypically different breast cancer cells. Apoptosis 2017, 22 (6), 800-815, 10.1007/s10495-017-1353-7
154. Sui, Y.; Yao, H.; Li, S.; Jin, L.; Shi, P.; Li, Z.; Wang, G.; Lin, S.; Wu, Y.; Li, Y.; Huang, L.; Liu, Q.; Lin, X. Delicaflavone induces autophagic cell death in lung cancer via Akt/mTOR/p70S6K signaling pathway. J. Mol. Med. (Heidelberg, Ger.) 2017, 95 (3), 311-322, 10.1007/s00109-016-1487-z
155. Lee, Y. J.; Kim, N. Y.; Suh, Y. A.; Lee, C. Involvement of ROS in Curcumin-induced Autophagic Cell Death. Korean J. Physiol. Pharmacol. 2011, 15 (1), 1-7, 10.4196/kjpp.2011.15.1.1
156. Tran, T. A.; Ahn, K. S.; Song, Y. W.; Moon, J. Y.; Cho, M.; Lim, Y.; Cho, S. K. Mechanism of 2′,3′-dimethoxyflavanone-induced apoptosis in breast cancer stem cells: role of ubiquitination of caspase-8 and LC3. Arch. Biochem. Biophys. 2014, 562, 92-102, 10.1016/j.abb.2014.08.001
157. Coussens, L. M.; Werb, Z. Inflammation and cancer. Nature 2002, 420 (6917), 860-7, 10.1038/nature01322
158. Balkwill, F.; Mantovani, A. Inflammation and cancer: back to Virchow?. Lancet 2001, 357 (9255), 539-45, 10.1016/S0140-6736(00)04046-0
159. Signore, A.; Capriotti, G.; Scopinaro, F.; Bonanno, E.; Modesti, A. Radiolabelled lymphokines and growth factors for in vivo imaging of inflammation, infection and cancer. Trends Immunol. 2003, 24 (7), 395-402, 10.1016/S1471-4906(03)00174-1
160. Sporn, M. B.; Roberts, A. B. Peptide growth factors and inflammation, tissue repair, and cancer. J. Clin. Invest. 1986, 78 (2), 329-32, 10.1172/JCI112580
161. Barton, B. E. IL-6-like cytokines and cancer cachexia. Immunol. Res. 2001, 23 (1), 41-58, 10.1385/IR:23:1:41
162. Macarthur, M.; Hold, G. L.; El-Omar, E. M. Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am. J. Physiol Gastrointest Liver Physiol 2004, 286 (4), G515-20, 10.1152/ajpgi.00475.2003
163. Moldawer, L. L.; Copeland, E. M. Proinflammatory cytokines, nutritional support, and the cachexia syndrome. Cancer 1997, 79 (9), 1828-1839, 10.1002/(SICI)1097-0142(19970501)79:9<1828::AID-CNCR28>3.0.CO;2-Z
164. Candido, J.; Hagemann, T. Cancer-related inflammation. J. Clin. Immunol. 2013, 33 (S1), 79-84, 10.1007/s10875-012-9847-0
165. Wung, B. S.; Hsu, M. C.; Wu, C. C.; Hsieh, C. W. Resveratrol suppresses IL-6-induced ICAM-1 gene expression in endothelial cells: effects on the inhibition of STAT3 phosphorylation. Life Sci. 2005, 78 (4), 389-97, 10.1016/j.lfs.2005.04.052
166. Mukherjee, S.; Siddiqui, M. A.; Dayal, S.; Ayoub, Y. Z.; Malathi, K. Epigallocatechin-3-gallate suppresses proinflammatory cytokines and chemokines induced by Toll-like receptor 9 agonists in prostate cancer cells. J. Inflammation Res. 2014, 7, 89-101, 10.2147/JIR.S61365
167. Moretti, M.; Bennett, J.; Tornatore, L.; Thotakura, A. K.; Franzoso, G. Cancer: NF-kappaB regulates energy metabolism. Int. J. Biochem. Cell Biol. 2012, 44 (12), 2238-43, 10.1016/j.biocel.2012.08.002
168. Baldwin, A. S., Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 1996, 14, 649-83, 10.1146/annurev.immunol.14.1.649
169. Ghosh, S.; May, M. J.; Kopp, E. B.; NF-kappa, B. and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 1998, 16, 225-260, 10.1146/annurev.immunol.16.1.225
170. Prasad, S.; Ravindran, J.; Aggarwal, B. B. NF-kappaB and cancer: how intimate is this relationship. Mol. Cell. Biochem. 2010, 336 (1-2), 25-37, 10.1007/s11010-009-0267-2
171. Sato, M.; Ozaki, M.; Nakanishi, K.; Watanabe, T.; Mino, K.; Yokoo, H.; Umezawa, K.; Ohmiya, Y.; Kamiyama, T.; Todo, S. A novel NF-kB inhibitor DHMEQ suppressed peritoneal dissemination of pancreatic cancer in mouse xenograft model. Eur. J. Cancer Suppl 2009, 7 (2), 402, 10.1016/S1359-6349(09)71365-5
172. Bours, V.; Dejardin, E.; Goujon-Letawe, F.; Merville, M.-P.; Castronovo, V. The NF-κB transcription factor and cancer: high expression of NF-κB- and IκB-related proteins in tumor cell lines. Biochem. Pharmacol. 1994, 47 (1), 145-149, 10.1016/0006-2952(94)90448-0
173. Sanchez-Fidalgo, S.; Villegas, I.; Rosillo, M. A.; Aparicio-Soto, M.; de la Lastra, C. A. Dietary squalene supplementation improves DSS-induced acute colitis by downregulating p38 MAPK and NFkB signaling pathways. Mol. Nutr. Food Res. 2015, 59 (2), 284-92, 10.1002/mnfr.201400518
174. Kawiak, A.; Domachowska, A. Plumbagin Suppresses the Invasion of HER2-Overexpressing Breast Cancer Cells through Inhibition of IKKalpha-Mediated NF-kappaB Activation. PLoS One 2016, 11 (10), e0164064, 10.1371/journal.pone.0164064
175. Johnsen, M.; Lund, L. R.; Rømer, J.; Almholt, K.; Danø, K. Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation. Curr. Opin. Cell Biol. 1998, 10 (5), 667-671, 10.1016/S0955-0674(98)80044-6
176. Wittekind, C.; Neid, M. Cancer invasion and metastasis. Oncology 2005, 69 (Suppl 1), 14-16, 10.1159/000086626
177. Friedl, P.; Alexander, S. Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 2011, 147 (5), 992-1009, 10.1016/j.cell.2011.11.016
178. Yodkeeree, S.; Chaiwangyen, W.; Garbisa, S.; Limtrakul, P. Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and uPA. J. Nutr. Biochem. 2009, 20 (2), 87-95, 10.1016/j.jnutbio.2007.12.003
179. Li, C.; Zhao, Y.; Yang, D.; Yu, Y.; Guo, H.; Zhao, Z.; Zhang, B.; Yin, X. Inhibitory effects of kaempferol on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-9. Biochem. Cell Biol. 2015, 93 (1), 16-27, 10.1139/bcb-2014-0067
180. Azios, N. G.; Dharmawardhane, S. F. Resveratrol and estradiol exert disparate effects on cell migration, cell surface actin structures, and focal adhesion assembly in MDA-MB-231 human breast cancer cells. Neoplasia 2005, 7 (2), 128-40, 10.1593/neo.04346
181. Bao, C.; Ko, J.; Park, H.-C.; Kim, M. C.; Kim, J.; Auh, J.-H.; Lee, H. J. Sulforaphane inhibited tumor necrosis factor-α induced migration and invasion in estrogen receptor negative human breast cancer cells. Food Sci. Biotechnol. 2015, 24 (1), 347-351, 10.1007/s10068-015-0046-7
182. Lu, Y.; Wei, C.; Xi, Z. Curcumin suppresses proliferation and invasion in non-small cell lung cancer by modulation of MTA1-mediated Wnt/beta-catenin pathway. In Vitro Cell. Dev. Biol.: Anim. 2014, 50 (9), 840-50, 10.1007/s11626-014-9779-5
183. Yang, C. L.; Liu, Y. Y.; Ma, Y. G.; Xue, Y. X.; Liu, D. G.; Ren, Y.; Liu, X. B.; Li, Y.; Li, Z. Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway. PLoS One 2012, 7 (5), e37960, 10.1371/journal.pone.0037960
184. Tsujii, M.; Kawano, S.; Tsuji, S.; Sawaoka, H.; Hori, M.; DuBois, R. N. Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells. Cell 1998, 93 (5), 705-716, 10.1016/S0092-8674(00)81433-6
185. Valtola, R.; Salven, P.; Heikkilä, P.; Taipale, J.; Joensuu, H.; Rehn, M.; Pihlajaniemi, T.; Weich, H.; deWaal, R.; Alitalo, K. VEGFR-3 and Its Ligand VEGF-C Are Associated with Angiogenesis in Breast Cancer. Am. J. Pathol. 1999, 154 (5), 1381-1390, 10.1016/S0002-9440(10)65392-8
186. Martiny-Baron, G.; Marmé, D. VEGF-mediated tumour angiogenesis: a new target for cancer therapy. Curr. Opin. Biotechnol. 1995, 6 (6), 675-680, 10.1016/0958-1669(95)80111-1
187. Carmeliet, P. VEGF as a key mediator of angiogenesis in cancer. Oncology 2005, 69 (3), 4-10, 10.1159/000088478
188. Luo, H.; Rankin, G. O.; Liu, L.; Daddysman, M. K.; Jiang, B. H.; Chen, Y. C. Kaempferol inhibits angiogenesis and VEGF expression through both HIF dependent and independent pathways in human ovarian cancer cells. Nutr. Cancer 2009, 61 (4), 554-63, 10.1080/01635580802666281
189. Bimonte, S.; Barbieri, A.; Palma, G.; Luciano, A.; Rea, D.; Arra, C. Curcumin inhibits tumor growth and angiogenesis in an orthotopic mouse model of human pancreatic cancer. BioMed Res. Int. 2013, 2013, 810423, 10.1155/2013/810423
190. Woodhouse, E. C.; Chuaqui, R. F.; Liotta, L. A. General mechanisms of metastasis. Cancer 1997, 80 (8 Suppl), 1529-1537, 10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F
191. Geiger, T. R.; Peeper, D. S. Metastasis mechanisms. Biochim. Biophys. Acta, Rev. Cancer 2009, 1796 (2), 293-308, 10.1016/j.bbcan.2009.07.006
192. Chen, C. C.; Sureshbabul, M.; Chen, H. W.; Lin, Y. S.; Lee, J. Y.; Hong, Q. S.; Yang, Y. C.; Yu, S. L. Curcumin Suppresses Metastasis via Sp-1, FAK Inhibition, and E-Cadherin Upregulation in Colorectal Cancer. Evid. Based Complement. Alternat. Med. 2013, 2013, 541695, 10.1155/2013/541695
193. Shanmugam, M. K.; Manu, K. A.; Ong, T. H.; Ramachandran, L.; Surana, R.; Bist, P.; Lim, L. H.; Kumar, A. P.; Hui, K. M.; Sethi, G. Inhibition of CXCR4/CXCL12 signaling axis by ursolic acid leads to suppression of metastasis in transgenic adenocarcinoma of mouse prostate model. Int. J. Cancer 2011, 129 (7), 1552-1563, 10.1002/ijc.26120
194. Chen, M. C.; Chang, W. W.; Kuan, Y. D.; Lin, S. T.; Hsu, H. C.; Lee, C. H. Resveratrol inhibits LPS-induced epithelial-mesenchymal transition in mouse melanoma model. Innate Immun. 2012, 18 (5), 685-93, 10.1177/1753425912436589
195. Kanaya, N.; Adams, L.; Takasaki, A.; Chen, S. Whole blueberry powder inhibits metastasis of triple negative breast cancer in a xenograft mouse model through modulation of inflammatory cytokines. Nutr. Cancer 2014, 66 (2), 242-8, 10.1080/01635581.2014.863366
196. Lee, R. C.; Feinbaum, R. L.; Ambros, V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75 (5), 843-54, 10.1016/0092-8674(93)90529-Y
197. Farazi, T. A.; Spitzer, J. I.; Morozov, P.; Tuschl, T. miRNAs in human cancer. J. Pathol 2011, 223 (2), 102-15, 10.1002/path.2806
198. Croce, C. M.; Calin, G. A. miRNAs, cancer, and stem cell division. Cell 2005, 122 (1), 6-7, 10.1016/j.cell.2005.06.036
199. Lam, T. K.; Shao, S.; Zhao, Y.; Marincola, F.; Pesatori, A.; Bertazzi, P. A.; Caporaso, N. E.; Wang, E.; Landi, M. T. Influence of quercetin-rich food intake on microRNA expression in lung cancer tissues. Cancer Epidemiol., Biomarkers Prev. 2012, 21 (12), 2176-84, 10.1158/1055-9965.EPI-12-0745
200. Appari, M.; Babu, K. R.; Kaczorowski, A.; Gross, W.; Herr, I. Sulforaphane, quercetin and catechins complement each other in elimination of advanced pancreatic cancer by miR-let-7 induction and K-ras inhibition. Int. J. Oncol. 2014, 45 (4), 1391-1400, 10.3892/ijo.2014.2539
201. Wang, H.; Bian, S.; Yang, C. S. Green tea polyphenol EGCG suppresses lung cancer cell growth through upregulating miR-210 expression caused by stabilizing HIF-1alpha. Carcinogenesis 2011, 32 (12), 1881-9, 10.1093/carcin/bgr218
202. Li, X.; Xie, W.; Xie, C.; Huang, C.; Zhu, J.; Liang, Z.; Deng, F.; Zhu, M.; Zhu, W.; Wu, R.; Wu, J.; Geng, S.; Zhong, C. Curcumin modulates miR-19/PTEN/AKT/p53 axis to suppress bisphenol A-induced MCF-7 breast cancer cell proliferation. Phytother. Res. 2014, 28 (10), 1553-60, 10.1002/ptr.5167
203. Hagiwara, K.; Gailhouste, L.; Yasukawa, K.; Kosaka, N.; Ochiya, T. A robust screening method for dietary agents that activate tumour-suppressor microRNAs. Sci. Rep. 2015, 5, 14697, 10.1038/srep14697
204. Chan, S. H.; Wang, L. H. Regulation of cancer metastasis by microRNAs. J. Biomed. Sci. 2015, 22, 9, 10.1186/s12929-015-0113-7
205. Song, B.; Wang, C.; Liu, J.; Wang, X.; Lv, L.; Wei, L.; Xie, L.; Zheng, Y.; Song, X. MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression. J. Exp. Clin. Cancer Res. 2010, 29, 29, 10.1186/1756-9966-29-29
206. Tili, E.; Croce, C. M.; Michaille, J. J. miR-155: on the crosstalk between inflammation and cancer. Int. Rev. Immunol. 2009, 28 (5), 264-84, 10.1080/08830180903093796
207. Tili, E.; Michaille, J. J.; Alder, H.; Volinia, S.; Delmas, D.; Latruffe, N.; Croce, C. M. Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGFbeta signaling pathway in SW480 cells. Biochem. Pharmacol. 2010, 80 (12), 2057-65, 10.1016/j.bcp.2010.07.003
208. Al Aameri, R. F. H.; Sheth, S.; Alanisi, E. M. A.; Borse, V.; Mukherjea, D.; Rybak, L. P.; Ramkumar, V. Tonic suppression of PCAT29 by the IL-6 signaling pathway in prostate cancer: Reversal by resveratrol. PLoS One 2017, 12 (5), e0177198, 10.1371/journal.pone.0177198
209. Hirata, H.; Ueno, K.; Nakajima, K.; Tabatabai, Z. L.; Hinoda, Y.; Ishii, N.; Dahiya, R. Genistein downregulates onco-miR-1260b and inhibits Wnt-signalling in renal cancer cells. Br. J. Cancer 2013, 108 (10), 2070-8, 10.1038/bjc.2013.173
210. Hussain, S. S.; Kumar, A. P.; Ghosh, R. Food-based natural products for cancer management: Is the whole greater than the sum of the parts?. Semin. Cancer Biol. 2016, 40-41, 233-246, 10.1016/j.semcancer.2016.06.002
211. Zhu, W.; Qin, W.; Zhang, K.; Rottinghaus, G. E.; Chen, Y. C.; Kliethermes, B.; Sauter, E. R. Trans-resveratrol alters mammary promoter hypermethylation in women at increased risk for breast cancer. Nutr. Cancer 2012, 64 (3), 393-400, 10.1080/01635581.2012.654926
212. Chen, J.; Song, Y.; Zhang, L. Lycopene/tomato consumption and the risk of prostate cancer: a systematic review and meta-analysis of prospective studies. J. Nutr. Sci. Vitaminol. 2013, 59 (3), 213-23, 10.3177/jnsv.59.213
213. Begley, C. G.; Ellis, L. M. Drug development: Raise standards for preclinical cancer research. Nature 2012, 483 (7391), 531-3, 10.1038/483531a
214. Vermeulen, L.; de Sousa e Melo, F.; Richel, D. J.; Medema, J. P. The developing cancer stem-cell model: clinical challenges and opportunities. Lancet Oncol. 2012, 13 (2), e83-e89, 10.1016/S1470-2045(11)70257-1
215. Aqil, F.; Munagala, R.; Jeyabalan, J.; Vadhanam, M. V. Bioavailability of phytochemicals and its enhancement by drug delivery systems. Cancer Lett. 2013, 334 (1), 133-41, 10.1016/j.canlet.2013.02.032
216. Thomasset, S. C.; Berry, D. P.; Garcea, G.; Marczylo, T.; Steward, W. P.; Gescher, A. J. Dietary polyphenolic phytochemicals - promising cancer chemopreventive agents in humans? A review of their clinical properties. Int. J. Cancer 2007, 120 (3), 451-8, 10.1002/ijc.22419
217. Maru, G. B.; Hudlikar, R. R.; Kumar, G.; Gandhi, K.; Mahimkar, M. B. Understanding the molecular mechanisms of cancer prevention by dietary phytochemicals: From experimental models to clinical trials. World J. Biol. Chem. 2016, 7 (1), 88-99, 10.4331/wjbc.v7.i1.88
218. Singh, C. K.; Ndiaye, M. A.; Ahmad, N. Resveratrol and cancer: Challenges for clinical translation. Biochim. Biophys. Acta, Mol. Basis Dis. 2015, 1852 (6), 1178-85, 10.1016/j.bbadis.2014.11.004
219. Reagan-Shaw, S.; Nihal, M.; Ahmad, N. Dose translation from animal to human studies revisited. FASEB J. 2008, 22 (3), 659-61, 10.1096/fj.07-9574LSF
220. Walle, T. Bioavailability of resveratrol. Ann. N. Y. Acad. Sci. 2011, 1215, 9-15, 10.1111/j.1749-6632.2010.05842.x
221. Yin, M. C.; Lin, M. C.; Mong, M. C.; Lin, C. Y. Bioavailability, distribution, and antioxidative effects of selected triterpenes in mice. J. Agric. Food Chem. 2012, 60 (31), 7697-701, 10.1021/jf302529x
222. Wang, S.; Su, R.; Nie, S.; Sun, M.; Zhang, J.; Wu, D.; Moustaid-Moussa, N. Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals. J. Nutr. Biochem. 2014, 25 (4), 363-76, 10.1016/j.jnutbio.2013.10.002
223. Balentine, D. A.; Wiseman, S. A.; Bouwens, L. C. The chemistry of tea flavonoids. Crit. Rev. Food Sci. Nutr. 1997, 37 (8), 693-704, 10.1080/10408399709527797
224. Amirdivani, S.; Baba, A. S. Green tea yogurt: major phenolic compounds and microbial growth. J. Food Sci. Technol. 2015, 52 (7), 4652-60, 10.1007/s13197-014-1670-6
225. Veitch, N. C. Isoflavonoids of the leguminosae. Nat. Prod. Rep. 2009, 26 (6), 776-802, 10.1039/b616809b
226. Wolfe, K. L.; Liu, R. H. Structure-activity relationships of flavonoids in the cellular antioxidant activity assay. J. Agric. Food Chem. 2008, 56 (18), 8404-11, 10.1021/jf8013074
227. Sanders, T. H.; McMichael, R. W.; Hendrix, K. W. Occurrence of Resveratrol in Edible Peanuts. J. Agric. Food Chem. 2000, 48 (4), 1243-1246, 10.1021/jf990737b
228. George, J.; Singh, M.; Srivastava, A. K.; Bhui, K.; Roy, P.; Chaturvedi, P. K.; Shukla, Y. Resveratrol and black tea polyphenol combination synergistically suppress mouse skin tumors growth by inhibition of activated MAPKs and p53. PLoS One 2011, 6 (8), e23395, 10.1371/journal.pone.0023395
229. Diretto, G.; Tavazza, R.; Welsch, R.; Pizzichini, D.; Mourgues, F.; Papacchioli, V.; Beyer, P.; Giuliano, G. Metabolic engineering of potato tuber carotenoids through tuber-specific silencing of lycopene epsilon cyclase. BMC Plant Biol. 2006, 6, 13, 10.1186/1471-2229-6-13
230. Yeh, C. T.; Wu, C. H.; Yen, G. C. Ursolic acid, a naturally occurring triterpenoid, suppresses migration and invasion of human breast cancer cells by modulating c-Jun N-terminal kinase, Akt and mammalian target of rapamycin signaling. Mol. Nutr. Food Res. 2010, 54 (9), 1285-95, 10.1002/mnfr.200900414
231. Hill, R. A.; Connolly, J. D. Triterpenoids. Nat. Prod. Rep. 2012, 29 (7), 780-818, 10.1039/c2np20027a
232. Chen, W.; Li, S.; Li, J.; Zhou, W.; Wu, S.; Xu, S.; Cui, K.; Zhang, D. D.; Liu, B. Artemisitene activates the Nrf2-dependent antioxidant response and protects against bleomycin-induced lung injury. FASEB J. 2016, 30 (7), 2500-10, 10.1096/fj.201500109R
233. Cordero-Herrera, I.; Martin, M. A.; Goya, L.; Ramos, S. Cocoa flavonoids protect hepatic cells against high-glucose-induced oxidative stress: relevance of MAPKs. Mol. Nutr. Food Res. 2015, 59 (4), 597-609, 10.1002/mnfr.201400492
234. Khan, S. G.; Katiyar, S. K.; Agarwal, R.; Mukhtar, H. Enhancement of antioxidant and phase II enzymes by oral feeding of green tea polyphenols in drinking water to SKH-1 hairless mice: possible role in cancer chemoprevention. Cancer Res. 1992, 52 (14), 4050-4052
235. Xu, X.; Li, H.; Hou, X.; Li, D.; He, S.; Wan, C.; Yin, P.; Liu, M.; Liu, F.; Xu, J. Punicalagin Induces Nrf2/HO-1 Expression via Upregulation of PI3K/AKT Pathway and Inhibits LPS-Induced Oxidative Stress in RAW264.7 Macrophages. Mediators Inflammation 2015, 2015, 380218, 10.1155/2015/380218
236. Guan, F.; Ding, Y.; Zhang, Y.; Zhou, Y.; Li, M.; Wang, C. Curcumin Suppresses Proliferation and Migration of MDA-MB-231 Breast Cancer Cells through Autophagy-Dependent Akt Degradation. PLoS One 2016, 11 (1), e0146553, 10.1371/journal.pone.0146553
237. Tong, W.; Wang, Q.; Sun, D.; Suo, J. Curcumin suppresses colon cancer cell invasion via AMPK-induced inhibition of NF-kappaB, uPA activator and MMP9. Oncol. Lett. 2016, 12 (5), 4139-4146, 10.3892/ol.2016.5148
238. Wahidur Rahman, K.; Li, Y.; Sarkar, F. H. Inactivation of Akt and NF-κB play important roles during indole-3-carbinol-induced apoptosis in breast cancer cells. Nutr. Cancer 2004, 48 (1), 84-94, 10.1207/s15327914nc4801-12
239. Luo, H.; Rankin, G. O.; Juliano, N.; Jiang, B. H.; Chen, Y. C. Kaempferol inhibits VEGF expression and in vitro angiogenesis through a novel ERK-NFkappaB-cMyc-p21 pathway. Food Chem. 2012, 130 (2), 321-328, 10.1016/j.foodchem.2011.07.045
240. Kleiner, D. E.; Stetler-Stevenson, W. G. Matrix metalloproteinases and metastasis. Cancer Chemother. Pharmacol. 1999, 43 (1), S42-S51, 10.1007/s002800051097
241. Bu, H. Q.; Liu, D. L.; Wei, W. T.; Chen, L.; Huang, H.; Li, Y.; Cui, J. H. Oridonin induces apoptosis in SW1990 pancreatic cancer cells via p53- and caspase-dependent induction of p38 MAPK. Oncol. Rep. 2014, 31 (2), 975-82, 10.3892/or.2013.2888
242. Kumar, D.; Shankar, S.; Srivastava, R. K. Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K/Akt/mTOR signaling pathway. Cancer Lett. 2014, 343 (2), 179-89, 10.1016/j.canlet.2013.10.003
243. Shi, S.; Cao, H. Shikonin promotes autophagy in BXPC-3 human pancreatic cancer cells through the PI3K/Akt signaling pathway. Oncol. Lett. 2014, 8, 1087-1089, 10.3892/ol.2014.2293
244. Shan, J. Z.; Xuan, Y. Y.; Zheng, S.; Dong, Q.; Zhang, S. Z. Ursolic acid inhibits proliferation and induces apoptosis of HT-29 colon cancer cells by inhibiting the EGFR/MAPK pathway. J. Zhejiang Univ., Sci., B 2009, 10 (9), 668-74, 10.1631/jzus.B0920149